Patent applications and USPTO patent grants for Santaris Pharma A/S.The latest application filed is for "potent lna oligonucleotides for the inhibition of hif-1a expression".
Patent | Date |
---|---|
Potent LNA oligonucleotides for the inhibition of HIF-1a expression Grant 9,447,138 - Westergaard , et al. September 20, 2 | 2016-09-20 |
Antisense design Grant 9,428,534 - Christensen , et al. August 30, 2 | 2016-08-30 |
Potent Lna Oligonucleotides For The Inhibition Of Hif-1a Expression App 20160229883 - Westergaard; Majken ;   et al. | 2016-08-11 |
Short interfering RNA (siRNA) analogues Grant 9,297,010 - Elmen , et al. March 29, 2 | 2016-03-29 |
Compositions and Methods for Modulation of ATXN3 Expression App 20150315595 - Uzcategui; Nathalie ;   et al. | 2015-11-05 |
MICROMIRs App 20150299699 - OBAD; Susanna ;   et al. | 2015-10-22 |
Anti Apob Antisense Conjugate Compounds App 20150291958 - Albaek; Nanna ;   et al. | 2015-10-15 |
Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides Grant 9,133,455 - Elmen , et al. September 15, 2 | 2015-09-15 |
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease App 20150252371 - Sazani; Peter L. ;   et al. | 2015-09-10 |
Amino-LNA, thio-LNA and alpha-L-oxy-LN Grant 9,045,518 - Christensen , et al. June 2, 2 | 2015-06-02 |
RNA antagonists targeting GLI2 for the treatment of leukemia Grant 9,040,493 - Zhang , et al. May 26, 2 | 2015-05-26 |
MicromiRs Grant 8,906,871 - Obad , et al. December 9, 2 | 2014-12-09 |
Splice Switching Oligomers For Tnf Superfamily Receptors And Their Use In Treatment Of Disease App 20140357849 - Orum; Henrik ;   et al. | 2014-12-04 |
Compounds For The Modulation Of Smn2 Splicing App 20140343127 - Kammler; Susanne | 2014-11-20 |
Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides App 20140329883 - ELMEN; Joacim ;   et al. | 2014-11-06 |
Compounds For The Modulation Of Beta-catenin Expression And Uses Thereof App 20140323557 - Dumble; Melissa ;   et al. | 2014-10-30 |
Antisense Design App 20140296502 - Christensen; Signe M. ;   et al. | 2014-10-02 |
Antisense Design App 20140288290 - Christensen; Signe M. ;   et al. | 2014-09-25 |
Process App 20140288299 - Meldgaard; Michael ;   et al. | 2014-09-25 |
Oligomeric compounds for the modulation of HIF-1A expression Grant 8,785,617 - Thrue , et al. July 22, 2 | 2014-07-22 |
Amino-lna, Thio-lna And Alpha-l-oxy-ln App 20140194614 - Christensen; Signe M. ;   et al. | 2014-07-10 |
Amino-lna, Thio-lna And Alpha-l-oxy-ln App 20140128586 - Christensen; Signe M. ;   et al. | 2014-05-08 |
Antisense Design App 20140128591 - Christensen; Signe M. ;   et al. | 2014-05-08 |
Bicyclonucleoside and oligonucleotide analogues Grant RE44,779 - Imanishi , et al. February 25, 2 | 2014-02-25 |
Short interfering RNA (siRNA) analogues Grant 8,653,252 - Elmen , et al. February 18, 2 | 2014-02-18 |
Methods For Treating Androgen Receptor Dependent Disorders Including Cancers App 20140031409 - Worm; Jesper ;   et al. | 2014-01-30 |
Short oligomer antagonist compounds for the modulation of target mRNA Grant 8,580,756 - Hansen , et al. November 12, 2 | 2013-11-12 |
Antisense oligomers targeting PCSK9 Grant 8,563,528 - Straarup , et al. October 22, 2 | 2013-10-22 |
Synthesis of locked nucleic acid derivatives Grant 8,492,390 - Detlef Sorensen , et al. July 23, 2 | 2013-07-23 |
Micro-RNA mediated modulation of colony stimulating factors Grant 8,492,357 - Worm , et al. July 23, 2 | 2013-07-23 |
RNA antagonist compounds for the inhibition of Apo-B100 expression Grant 8,470,791 - Hansen , et al. June 25, 2 | 2013-06-25 |
RNA antagonist compounds for the modulation of PIK3CA expression Grant 8,450,291 - Hedtjarn May 28, 2 | 2013-05-28 |
Methods for treating androgen receptor dependent disorders including cancers Grant 8,450,290 - Worm , et al. May 28, 2 | 2013-05-28 |
RNA antagonists targeting Hsp27 Grant 8,440,809 - Worm May 14, 2 | 2013-05-14 |
Combination treatment for the treatment of hepatitis C virus infection Grant 8,440,637 - Elmen May 14, 2 | 2013-05-14 |
Oligomeric Compounds For The Modulation Of Hif-1a Expression App 20130116309 - Thrue; Charlotte Albaek ;   et al. | 2013-05-09 |
Potent LNA oligonucleotides for the inhibition of HIF-1A expression Grant 8,410,071 - Westergaard , et al. April 2, 2 | 2013-04-02 |
Pharmaceutical compositions for treatment of MicroRNA related diseases Grant 8,404,659 - Kauppinen , et al. March 26, 2 | 2013-03-26 |
Pharmaceutical compositions for treatment of microRNA related diseases Grant 8,361,980 - Kauppinen , et al. January 29, 2 | 2013-01-29 |
Lna Oligonucleotides And The Treatment Of Cancer App 20120322848 - Rosenbohm; Christoph ;   et al. | 2012-12-20 |
Small internally segmented interfering RNA Grant 8,329,888 - Wengel , et al. December 11, 2 | 2012-12-11 |
Rna Antagonist Compounds For The Modulation Of Her3 App 20120295955 - Hedtjarn; Maj | 2012-11-22 |
Oligomeric Compounds For The Modultion of HIF-1A Expression App 20120270924 - Thrue; Charlotte Alb.ae butted.k ;   et al. | 2012-10-25 |
MicroRNAs Grant 8,288,356 - Obad , et al. October 16, 2 | 2012-10-16 |
Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides App 20120238618 - Elmen; Joacim ;   et al. | 2012-09-20 |
RNA antagonist compounds for the modulation of HER3 Grant 8,268,793 - Hedtjarn September 18, 2 | 2012-09-18 |
Synthesis Of Locked Nucleic Acid Derivatives App 20120165514 - Sorensen; Mads Detlef ;   et al. | 2012-06-28 |
Oligomeric compounds for the modulation of HIF-1.alpha. expression Grant 8,207,140 - Thrue , et al. June 26, 2 | 2012-06-26 |
Micro-RNA Mediated Modulation of Colony Stimulating Factors App 20120115924 - Worm; Jesper ;   et al. | 2012-05-10 |
LNA oligonucleotides and the treatment of cancer Grant 8,173,428 - Rosenbohm , et al. May 8, 2 | 2012-05-08 |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotide Grant 8,163,708 - Elmen , et al. April 24, 2 | 2012-04-24 |
Oligomeric Compounds For The Modulation Of Survivin Expression App 20120088907 - Hansen; Bo ;   et al. | 2012-04-12 |
Pharmaceutical Composition App 20120083596 - Elmen; Joacim ;   et al. | 2012-04-05 |
Methods Of Treating Cancers With Her3 Antisense Oligonucleotides App 20120076781 - Zhang; Yixian ;   et al. | 2012-03-29 |
Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease App 20120040917 - ORUM; HENRIK ;   et al. | 2012-02-16 |
Compounds For The Modulation Of Beta-catenin Expression App 20120004288 - WORM; Jesper | 2012-01-05 |
Lna Antagonists Targeting The Androgen Receptor App 20110319471 - WORM; Jesper | 2011-12-29 |
Synthesis of locked nucleic acid derivatives Grant 8,084,458 - Sorensen , et al. December 27, 2 | 2011-12-27 |
Compounds for the modulation of beta-catenin expression Grant 8,039,446 - Worm October 18, 2 | 2011-10-18 |
Oligomeric compounds for the modulation of survivin expression Grant 8,026,355 - Hansen , et al. September 27, 2 | 2011-09-27 |
LNA antagonists targeting the androgen receptor Grant 7,989,429 - Worm August 2, 2 | 2011-08-02 |
Potent LNA oligonucleotides for the inhibition of HIF-1a expression Grant 7,939,507 - Westergaard , et al. May 10, 2 | 2011-05-10 |
Compounds For The Modulation Of Beta-catenin Expression App 20110086902 - WORM; Jesper | 2011-04-14 |
Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases App 20110077288 - Kauppinen; Sakari ;   et al. | 2011-03-31 |
Compounds for the modulation of beta-catenin expression Grant 7,915,401 - Worm March 29, 2 | 2011-03-29 |
RNA antagonist compounds for the modulation of PIK3CA expression Grant 7,863,437 - Hedtjarn January 4, 2 | 2011-01-04 |
RNA Antagonist Compounds for the Modulation of MCL-1 App 20100323967 - Hansen; Jens Bo Rode ;   et al. | 2010-12-23 |
Oligomeric compounds for the modulation of HIF-1alpha expression Grant 7,846,911 - Thrue , et al. December 7, 2 | 2010-12-07 |
MICROMIRs App 20100298410 - Obad; Susana ;   et al. | 2010-11-25 |
Combination Treatment For The Treatment of Hepatitis C Virus Infection App 20100280099 - Elmen; Joacim | 2010-11-04 |
RNA Antagonist Compounds for the Inhibition of Apo-B100 Expression App 20100227914 - Hansen; Henrik Frydenlund ;   et al. | 2010-09-09 |
Soluble TNF receptors and their use in treatment of disease Grant 7,785,834 - Sazani , et al. August 31, 2 | 2010-08-31 |
Short RNA Antagonist Compounds for the Modulation of Target mRNA App 20100210712 - Hansen; Jens Bo Rode ;   et al. | 2010-08-19 |
Oligomeric compounds for the modulation of survivin expression Grant 7,741,309 - Hansen , et al. June 22, 2 | 2010-06-22 |
LNA antagonists targeting the androgen receptor Grant 7,737,125 - Worm June 15, 2 | 2010-06-15 |
Oligomeric compounds for the modulation HIF-1.alpha. expression Grant 7,737,264 - Thrue , et al. June 15, 2 | 2010-06-15 |
Oligomeric compounds for the modulation of survivin expression Grant 7,713,738 - Hansen , et al. May 11, 2 | 2010-05-11 |
Oligonucleotides with alternating segments of locked and non-locked nucleotides Grant 7,687,617 - Thrue , et al. March 30, 2 | 2010-03-30 |
Adenosine Receptor Antagonists App 20100062994 - Ravn; Jacob ;   et al. | 2010-03-11 |
Pharmaceutical Composition App 20100004320 - Elmen; Joacim ;   et al. | 2010-01-07 |
Pharmaceutical compositions for treatment of microRNA related diseases App 20090298916 - Kauppinen; Sakari ;   et al. | 2009-12-03 |
Oligomeric compounds for the modulation of Bcl-2 Grant 7,622,453 - Frieden , et al. November 24, 2 | 2009-11-24 |
Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease App 20090264353 - Orum; Henrik ;   et al. | 2009-10-22 |
Potent LNA oligonucleotides for the inhibition of HIF-1A expression Grant 7,589,190 - Westergaard , et al. September 15, 2 | 2009-09-15 |
Oligonucleotides With Alternating Segments Of Locked And Non-locked Nucleotides App 20090209748 - Thrue; Charlotte Albaek ;   et al. | 2009-08-20 |
Compounds For The Modulation Of Beta-catenin Expression App 20090203137 - Worm; Jesper | 2009-08-13 |
Synthesis of locked nucleic acid derivatives Grant 7,569,575 - Sorensen , et al. August 4, 2 | 2009-08-04 |
Rna Antagonist Compounds For The Modulation Of Pik3ca Expression App 20090192110 - Hedtjarn; Maj | 2009-07-30 |
Lna Oligonucleotides And The Treatment Of Cancer App 20090181914 - ROSENBOHM; CHRISTOPH ;   et al. | 2009-07-16 |
MICROMIRs App 20090143326 - Obad; Susanna ;   et al. | 2009-06-04 |
Compounds For The Modulation Of Beta-catenin Expression App 20090005335 - Worm; Jesper | 2009-01-01 |
Rna Antagonist Compounds For The Modulation Of Her3 App 20080318894 - Hedtjarn; Maj | 2008-12-25 |
Modified Short Interfering Rna (Modified Sirna) App 20080249039 - Elmen; Joacim ;   et al. | 2008-10-09 |
Short interfering rna (sirna) analogues App 20070191294 - Elmen; Joacim ;   et al. | 2007-08-16 |
Method for preparation of LNA phosphoramidites Grant 7,153,954 - Koch , et al. December 26, 2 | 2006-12-26 |
Potent LNA oligonucleotides for the inhibition of HIF-1a expression App 20060252721 - Westergaard; Majken ;   et al. | 2006-11-09 |
LNA oligonucleotides and the treatment of cancer App 20060154888 - Rosenbohm; Christoph ;   et al. | 2006-07-13 |
Antisense design App 20060128646 - Christensen; Signe M. ;   et al. | 2006-06-15 |
Synthesis of purine locked nucleic acid analogues Grant 6,998,484 - Koch , et al. February 14, 2 | 2006-02-14 |
Oligomeric compounds for the modulation of Bcl-2 App 20050203042 - Frieden, Miriam ;   et al. | 2005-09-15 |
Synthesis of allofuranose Grant 6,858,726 - Koch , et al. February 22, 2 | 2005-02-22 |
Oligomeric compounds for the modulation of ras expression App 20040248840 - Hansen, Bo ;   et al. | 2004-12-09 |
Oligomeric compounds for the modulation of thioredoxin expression App 20040241717 - Hansen, Bo ;   et al. | 2004-12-02 |
SEC | 0001607648 | SANTARIS PHARMA A/S |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.